Clinical Trial Update: Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing secukinumab to placebo, in combination with a glucocorticoid taper regimen, in patients with Polymyalgia Rheumatica has completed. The u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: COMPLETED